13.5 EUR
0.13
0.97%
Last update Dec 18, 9:50 PM CET
Market closed
Day range
13.20500
13.70000
Previous close
13.37000
Open
13.20500
Access this stock data via API
Subscribe
Aurinia Pharmaceuticals Inc.
13.50
0.13
0.97%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 200.4M 175.5M 134.0M 45.6M
Cost of revenue 24.1M 14.1M 5.7M 1.1M
Gross profit 176.4M 161.4M 128.4M 44.5M
Operating expense
Research & development 17.7M 49.6M 45.0M 51.1M
Selling general and admin 146.7M 195.0M 196.4M 173.5M
Other operating expenses -3.7M 8.4M -1.5M 574K
Operating income 15.7M -91.7M -111.5M -180.7M
Non operating interest income
Income 14.5M 17.0M 5.1M 529K
Expense 4.1M 2.8M 0 0
Other income expense -19.7M
Pretax income 6.3M -77.5M -106.4M -180.2M
Tax provision 1.4M 551K 1.8M 760K
Net income 4.9M -78.0M -108.2M -181.0M
Basic EPS 0.0 -0.5 -0.8 -1.4
Diluted EPS 0.0 -0.5 -0.8 -1.4
Basic average shares 122.0M 148.9M 145.7M 132.8M
Diluted average shares 122.0M 148.9M 145.7M 132.8M
EBITDA 46.7M -63.0M -103.6M -177.4M
Net income from continuing op. 4.9M -78.0M -108.2M -181.0M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 7 hours 15 minutes

00:44
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).